Skip to main content
Clinical Trials/NCT02558569
NCT02558569
Completed
Phase 4

The Use of Fentanyl in General Anesthesia for Craniotomy With or Without 0.5% Levobupivacaine Scalp Block: A Randomized Controlled Trial

Mahidol University2 sites in 1 country128 target enrollmentSeptember 2015

Overview

Phase
Phase 4
Intervention
Levobupivacaine
Conditions
Brain Tumor
Sponsor
Mahidol University
Enrollment
128
Locations
2
Primary Endpoint
The total dose of fentanyl being used during craniotomy
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study evaluates the use of fentanyl during craniotomy in two groups of brain tumor patients. The control group will receive standard general anesthesia with the use of fentanyl for intraoperative pain control and the study group will receive scalp nerve block with 0.5% levobupivacaine (local anesthetic) and also fentanyl for intraoperative pain control. The scalp nerve block might reduce the dose of fentanyl and promote faster emergence from general anesthesia.

Detailed Description

Fentanyl has widely been used for intraoperative analgesia for craniotomy. In craniotomy, the long and complex operation, the continuous infusion or repeated use of fentanyl can significantly delay emergence from general anesthesia. The scalp block with local anesthesia is widely used for awake craniotomy with great success but it is not routinely used in general craniotomy. In this study, the control group will receive standard general anesthesia with the use of fentanyl for intraoperative pain control and the study group will receive the addition of scalp nerve block with 0.5% levobupivacaine (local anesthetic). The scalp nerve block might reduce the total dose of fentanyl and promote faster emergence from general anesthesia.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
August 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Manee Raksakietisak

Associate professor

Mahidol University

Eligibility Criteria

Inclusion Criteria

  • supratentorial brain tumor

Exclusion Criteria

  • tumor size\>4 cm
  • Glasgow Coma Score (GCS) \<15
  • already intubated
  • uncontrolled hypertension
  • can not communicate

Arms & Interventions

Levobupivacaine

Scalp nerve block with 0.5% Levobupivacaine adds up to intravenous fentanyl for intraoperative pain control during supratentorial craniotomy with brain tumor removal. The scalp block includes 4-6 nerves which give sensory supply to related location with the use of total 10-15 ml of 0.5% Levobupivacaine. Intravenous fentanyl is used for intraoperative analgesia in both groups with continuous infusion (1 mcg/kg/hr until opening of dura and then 0.5 mcg/kg/hr until finishing of dural closure) and increment doses (0.5 mcg/kg) also given. is used for intraoperative analgesia in both groups with continuous infusion (1 mcg/kg/hr until opening of dura and then 0.5 mcg/kg/hr until finishing of dural closure) and increment doses (0.5 mcg/kg) also given.

Intervention: Levobupivacaine

NSS

Scalp nerve block with 10-15 ml of 0.9% sodium chloride(NaCl), or normal saline (NSS) includes 4-6 nerves which give sensory supply to related location (sham block). Intravenous fentanyl is used for intraoperative analgesia in both groups with continuous infusion (1 mcg/kg/hr until opening of dura and then 0.5 mcg/kg/hr until finishing of dural closure) and increment doses (0.5 mcg/kg) also given.

Intervention: NSS

Outcomes

Primary Outcomes

The total dose of fentanyl being used during craniotomy

Time Frame: One day

Total dose of fentanyl use during operative period

Secondary Outcomes

  • Awakening time from general anesthesia(One day)

Study Sites (2)

Loading locations...

Similar Trials